TransCure bioServices

TransCure bioServices, a Taconic Biosciences company

Rethinking preclinical research with your goals in mind.

TransCure bioServices accelerates drug development by delivering the right humanized models, the right data, and the right partnership mindset.

As part of Taconic Biosciences, a global leader in genetically engineered and humanized mouse models, we offer a fully integrated translational research platform, combining world-class models with advanced in vivo preclinical services.

Our humanized mouse platforms generate robust, translatable in vivo data to support critical decision-making in:

- Oncology (Human CDX, Human PDX, Syngeneic Models)

- Inflammatory diseases (IBD, MASH, GvHD, Lung Inflammation)

- Infectious diseases & toxicity (HIV, HBV, Immunotoxicity, Hepatotoxicity)

Every study is co-designed with your team to align with your scientific strategy, timelines, and regulatory requirements - keeping you in control, while we manage the complexity.

Based in France (near Geneva), our AAALAC-accredited, BSL-2 and BSL-3 facilities, combined with highly experienced scientific teams, ensure the highest standards of quality, safety, and animal welfare.

With over 12 years of expertise and hundreds of completed studies, TransCure bioServices proudly supports biotech, pharma, and academic partners worldwide from early discovery to clinical readiness.